BCL2L1 and acute lymphoblastic leukemia: To investigate whether MCL-1 and BCL-XL mediate resistance to apoptosis induction by venetoclax, we used dynamic BH3 profiling analyzing dependencies of BCP-ALL cells on different anti-apoptotic proteins in response to treatment with a specific drug [21], in our case venetoclax.